ES8601869A1 - Crystalline cefuroxime axetil - Google Patents

Crystalline cefuroxime axetil

Info

Publication number
ES8601869A1
ES8601869A1 ES534695A ES534695A ES8601869A1 ES 8601869 A1 ES8601869 A1 ES 8601869A1 ES 534695 A ES534695 A ES 534695A ES 534695 A ES534695 A ES 534695A ES 8601869 A1 ES8601869 A1 ES 8601869A1
Authority
ES
Spain
Prior art keywords
cefuroxime axetil
crystalline cefuroxime
crystalline
mixts
solns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534695A
Other languages
Spanish (es)
Other versions
ES534695A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES534695A0 publication Critical patent/ES534695A0/en
Publication of ES8601869A1 publication Critical patent/ES8601869A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Prepn. of very pure, crystalline 1-acetoxy-ethyl ester of cefuroxime (I) comprises crystallisation of (I) from solns. in organic or aq. solvents or their mixts. followed by isolation and drying of the prod.
ES534695A 1983-07-29 1984-07-27 Crystalline cefuroxime axetil Expired ES8601869A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320521A GB8320521D0 (en) 1983-07-29 1983-07-29 Chemical process

Publications (2)

Publication Number Publication Date
ES534695A0 ES534695A0 (en) 1985-11-01
ES8601869A1 true ES8601869A1 (en) 1985-11-01

Family

ID=10546505

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534695A Expired ES8601869A1 (en) 1983-07-29 1984-07-27 Crystalline cefuroxime axetil

Country Status (21)

Country Link
JP (1) JPH0613526B2 (en)
KR (1) KR910008377B1 (en)
AT (1) AT392470B (en)
AU (2) AU582121B2 (en)
BE (1) BE900241A (en)
CA (1) CA1265511A (en)
CH (1) CH662121A5 (en)
DE (1) DE3427828A1 (en)
DK (1) DK165505C (en)
ES (1) ES8601869A1 (en)
FI (1) FI76808C (en)
FR (1) FR2549837B1 (en)
GB (2) GB8320521D0 (en)
IE (1) IE57726B1 (en)
IL (1) IL72536A (en)
NL (1) NL8402372A (en)
NO (1) NO167292C (en)
NZ (1) NZ209046A (en)
PT (1) PT78985B (en)
SE (1) SE463263B (en)
ZA (1) ZA845830B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
IT1277426B1 (en) * 1995-08-03 1997-11-10 Acs Dobfar Spa BIOAVAILABLE CRYSTALLINE FORM OF CEFUROXIMA AXETIL
CN1111537C (en) * 1997-05-15 2003-06-18 第一制糖株式会社 The preparation method of highly pure crystalline form of cefuroxime axetil
KR100228264B1 (en) * 1997-08-02 1999-11-01 김선진 The synthetic method of crystalline cefuroxime axetil
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (en) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
DK0937727T3 (en) * 1998-02-20 2002-05-13 Fako Ilaclari A S Process for the preparation of soluble crystalline cefuroxime axetil
IN190849B (en) 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
AT411996B (en) 2000-09-11 2004-08-26 Sandoz Ag METHOD FOR PRODUCING CEFUROXIME IN THE FORM OF ITS N-BUTYL LAMONIUM SALTS
ITMI20011763A1 (en) * 2001-08-10 2003-02-10 Antibioticos Spa HIGH-PURITY CEFUROXIME AXELITE PREPARATION PROCESS
ITMI20011925A1 (en) * 2001-09-14 2003-03-14 Antibioticos Spa METHOD APPLICABLE ON INDUSTRIAL SCALE FOR THE PREPARATION OF CEFUROXIME AXETILE CRISTALLINO
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN100448879C (en) * 2004-07-22 2009-01-07 北京化工大学 Method for preparing unformed cefuroxime axetil
DE102005019458A1 (en) 2005-04-25 2006-10-26 Grünenthal GmbH Composition, useful in the preparation of pellets and the multi-particular-presentation form, comprises cefuroximaxetil and carrageenan of the group of lambda carrageenan, tau carrageenan and kappa carrageenan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
JPS577485A (en) * 1980-06-13 1982-01-14 Takeda Chem Ind Ltd Cephalosporin
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
GB2145409B (en) 1987-02-18
AU634965B2 (en) 1993-03-11
DK366684A (en) 1985-01-30
AT392470B (en) 1991-04-10
DK165505C (en) 1993-04-19
NL8402372A (en) 1985-02-18
FI843011A0 (en) 1984-07-27
IL72536A (en) 1988-01-31
FR2549837B1 (en) 1986-12-26
PT78985A (en) 1984-08-01
CA1265511A (en) 1990-02-06
FI76808C (en) 1988-12-12
ES534695A0 (en) 1985-11-01
ATA244484A (en) 1990-09-15
NO843055L (en) 1985-01-30
ZA845830B (en) 1986-03-26
DK165505B (en) 1992-12-07
FI76808B (en) 1988-08-31
NO167292B (en) 1991-07-15
IE841938L (en) 1985-01-29
JPS6075484A (en) 1985-04-27
CH662121A5 (en) 1987-09-15
GB2145409A (en) 1985-03-27
IL72536A0 (en) 1984-11-30
JPH0613526B2 (en) 1994-02-23
AU582121B2 (en) 1989-03-16
GB8320521D0 (en) 1983-09-01
NZ209046A (en) 1988-02-29
IE57726B1 (en) 1993-03-24
SE463263B (en) 1990-10-29
NO167292C (en) 1991-10-23
BE900241A (en) 1985-01-28
PT78985B (en) 1986-10-23
AU3125684A (en) 1985-01-31
SE8403897D0 (en) 1984-07-27
DE3427828A1 (en) 1985-02-14
SE8403897L (en) 1985-01-30
KR850001221A (en) 1985-03-16
GB8419202D0 (en) 1984-08-30
FR2549837A1 (en) 1985-02-01
DK366684D0 (en) 1984-07-27
KR910008377B1 (en) 1991-10-12
AU3660189A (en) 1989-10-05
FI843011A (en) 1985-01-30

Similar Documents

Publication Publication Date Title
ES8601869A1 (en) Crystalline cefuroxime axetil
AU1615788A (en) Cefuroxime axetil compositions
SG70980A1 (en) Novel 4-arylpiperazines and 4-arylpiperidines
NO895160D0 (en) MICROBIAL PROCEDURE FOR THE PREPARATION OF IMMUNIBLE ANTIBIOTICS.
IT8021822A0 (en) HETEROCYCLYL DERIVATIVES OF OXI-IMINO-SUBSTITUTED CEPHALOSPORINS.
AU2371184A (en) 2-imino-pyrrolidines
ES452650A1 (en) Process for cephalosporin antibiotic intermediates
YU202786A (en) Process for obtaining coloidic basis gel containing primicine
FI934395A (en) 2-SPYROCYKLOPROPYL 4-ACYLCEPHEMI SAMT FOERFARANDE FOER FRAMSTAELLNING DAERAV
ZA907976B (en) Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
GB1547473A (en) Cephalosporin compounds
AU2240388A (en) Azachromane derivatives
AU570070B2 (en) Dibromobenzylcyclohexylamine compounds for the treatment of infections
NO942218D0 (en) Process for the preparation of carbonate composition
AU638829B2 (en) Composition for disinfecting water by the electrochlorination process and use of this composition
AU516917B2 (en) 7-(2,3-dihydrobenzo-5-furanyl)acetamido cephalosporin derivatives
FI873464A (en) PROCEDURE FOR FRAMSTATION OF ANTIBACTERIAL 7-OXO-4-THIA-1-AZABICYCLO (3.2.0) HEPT-2-ENE DERIVAT.
JPS57185292A (en) Cephem derivative and manufacture
JPS53101365A (en) Peptides
NO890287D0 (en) PREPARATION OF BETA-LACTAM ANTIBIOTICS.
ES8107309A1 (en) 7 alpha -Methoxycephalosporin derivatives
JPS5219691A (en) Preparation of 3-substituted methyl-3- cephem derivatives
JPS53105583A (en) Polysaccharide sulfate derivative
JPS524009A (en) Dc motor driving circuit
AU4188189A (en) Isolation, purification, and characterization of the aminopeptidases: mas ii and mas iii